The Renegade PHEV should end up in public hands in early 2020.
Intel launches 9th-gen, 8-core i9-9900K CPU and more – CNET
This is the processor you’ll want to pair with your Nvidia RTX 2080 Ti card.
Big discoveries about tiny particles
Understanding the mechanical properties of nanoparticles are essential to realizing their promise in being used to create exciting new products. This new research has taken a significant step toward gaining the knowledge that can lead to better performance with products using polymer nanoparticles.
Star Wars News: Kathleen Kennedy Isn’t Going Anywhere
The Lucasfilm president just extended her contract for three more years.
How JUMP Designed a Global Electric Bike
The secret to building a bike that can serve all kinds of riders across the country—and soon, the world.
Facebook Portal: Price, Specs, Release Date
Facebook made you a device for your home that has a camera on it. Neat!
With Project xCloud, Xbox Wants to Bring Gaming Anywhere You Are
Cloud gaming is a long-held dream, but Xbox is harnessing the power of Microsoft to make it happen—for real this time.
Annual price tag for nonfatal injuries in the US tops $1.8 trillion
Almost one in 10 people in the US visited the hospital for nonfatal injuries in 2013 for a total cost of $1.8 trillion. Falls and being hit by objects were the most prevalent causes of injury.
Pregnant women recognize baby expressions differently depending on mental health history
A pilot study has found that pregnant women who have suffered from depression or bipolar disorder (i.e. both mania and depression) recognize babies’ faces and how babies laugh or cry, differently to healthy controls. This happens even if they are not currently experiencing depressive or manic symptoms and may represent an early risk-factor for children of these women, although the authors stress that research would be needed to confirm any long-term effects.
Novel technology enables detection of early-stage lung cancer when surgical cure still is possible
To improve outcomes for patients with non-small-cell lung carcinoma researchers are developing a blood test to detect lung cancer earlier in the disease. A report describes a new technology, electric field-induced release and measurement (EFIRM) that is both highly sensitive and specific in detecting two epidermal growth factor receptor (EGFR) mutations associated with lung cancer in the blood of NSCLC patients with early-stage disease. This platform is relatively inexpensive and capable of high-throughput testing.